Buffalo diagnostics company Empire Genomics is readying itself to acquire new technologies, grow its staff and increase its test offerings.
It plans to do so with $1 million in recent financing from Rand Capital and Buffalo-area incubator Z80 Labs.
Empire Genomics was launched in 2006 at the Roswell Cancer Institute in Buffalo, New York. The lab develops high throughput technologies to allow for genome-wide analyses aimed at understanding the underlying mechanisms that cause disease, particularly cancer.
The company has been planning for some time now to grow its employee count — it announced a five-year plan in 2012 to add 50 new workers to its offices that border the Buffalo Niagara Medical Campus.
Earlier this year, Empire Genomics was included in a $105 million genomic research consortium funded by the state of New York that’s made up of companies in both Buffalo and Manhattan.
